Walpar Nutritions (NSE:WALPAR) Notes Receivable: ₹0.0 Mil (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:WALPAR Walpar Nutritions Ltd NSE:WALPAR
54 GF Score
Price ₹34.50
View Full Analysis

What is Walpar Nutritions Notes Receivable?

Walpar Nutritions NSE:WALPAR 54 Notes Receivable is ₹0.0 Mil as of Mar. 2024. GuruFocus rates NSE:WALPAR with a GF Score™ of 54/100.

Walpar Nutritions's Notes Receivable for the quarter that ended in Mar. 2024 was ₹0.0 Mil.


Walpar Nutritions Notes Receivable Related Terms


Walpar Nutritions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Walpar Nutritions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walpar Nutritions Notes Receivable Chart

Walpar Nutritions Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Walpar Nutritions Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:WALPAR
54GF Score
Walpar Nutritions Ltd NSE:WALPAR
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Walpar Nutritions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Walpar Nutritions (NSE:WALPAR) has a Notes Receivable of ₹0.0 Mil as of Mar. 2024. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Walpar Nutritions and its competitors.
Is Walpar Nutritions' Notes Receivable too high?
Walpar Nutritions' current Notes Receivable is ₹0.0 Mil. Overall, Walpar Nutritions has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Walpar Nutritions' Notes Receivable compare to ZTS and VTRS?
Walpar Nutritions' Notes Receivable of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Walpar Nutritions and its competitors. Walpar Nutritions's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walpar Nutritions stock overvalued right now?
Walpar Nutritions (NSE:WALPAR) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Walpar Nutritions' overall GF Score™ is 54/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Walpar Nutritions (NSE:WALPAR), the current Notes Receivable is ₹0.0 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walpar Nutritions Business Description

Address Khatraj, 2nd Floor L5:377 Plot No 5, Omkar Estate, Opposite Sabarmati Gas Station, Kalol, Gandhinagar, GJ, IND, 382721
Walpar Nutritions Ltd is India-based company, which is engaged in manufacturing and trading of pharmaceutical, nutraceutical, herbal and ayurvedic commodities. It also manufactures various private label/third party brands for different companies across the country and overseas, as well as for their own brand sales. It is a manufacturer of various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceutical formulations. It specializes in contract manufacturing, raw materials trading, and direct selling. Its portfolio consists of tablets, capsules, powder/sachets, and oral liquids.
54GF Score

Get the complete analysis for NSE:WALPAR

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.50
Price